Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Globus Medical
(NYSE:GMED)
Intraday
$63.00
11.64
[22.66%]
15 minutes delayed
Get Report
Watch
Perks
Buy
Compare Brokers
$63.00
11.64
[22.66%]
Last update: 1:11PM
Get Real Time Here
Why is it moving?
Globus Medical shares are trading higher after the company reported better-than-expected Q1 financial results and raised its FY24 guidance.
Get Report
Watch
Q1 2024 Earnings were released on Tue May 7th, after the market close
The most recent conference call was at 16:30 PM, 1 day ago
Click to view past webcast
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for Globus Medical Stock (NYSE:GMED)
Globus Medical Stock (NYSE: GMED)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, May 08, 2024
BTIG Maintains Buy on Globus Medical, Raises Price Target to $63
Benzinga Newsdesk
-
48 minutes ago
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights
-
55 minutes ago
Piper Sandler Maintains Neutral on Globus Medical, Raises Price Target to $60
Benzinga Newsdesk
-
1 hour ago
Louisiana-Pacific Posts Upbeat Results, Joins Cricut, Elanco Animal, American Public Education And Other Big Stocks Moving Higher On Wednesday
Avi Kapoor
-
2 hours ago
Stifel Maintains Buy on Globus Medical, Raises Price Target to $70
Benzinga Newsdesk
-
4 hours ago
Needham Reiterates Hold on Globus Medical
Benzinga Newsdesk
-
5 hours ago
Globus Medical shares are trading higher after the company reported better-than-expected Q1 financial results and raised its FY24 guidance.
Benzinga Newsdesk
-
5 hours ago
Tuesday, May 07, 2024
Globus Medical shares are trading higher after the company reported better-than-expected Q1 financial results and raised its FY24 guidance.
Benzinga Newsdesk
-
20 hours ago
Globus Medical Revises FY24 EPS From $2.68-$2.70 To $2.75-$2.85 Vs $2.69 Est.; Revenue From $2.45B-$2.475B To $2.46B-$2.485B Vs $2.46B Est.
Benzinga Newsdesk
-
20 hours ago
Globus Medical Q1 EPS $0.72 Beats $0.57 Estimate, Sales $606.67M Beat $587.14M Estimate
Benzinga Newsdesk
-
21 hours ago
Thursday, April 04, 2024
Globus Medical (GMED) Gains From New Launches Amid Macro Issues
Zacks
-
Apr 4, 2024, 1:29PM
Monday, March 18, 2024
The Latest Analyst Ratings For Globus Medical
Benzinga Insights
-
Mar 18, 2024, 11:01AM
BTIG Upgrades Globus Medical to Buy, Announces $60 Price Target
Benzinga Newsdesk
-
Mar 18, 2024, 8:06AM
Wednesday, February 21, 2024
Canaccord Genuity Reiterates Buy on Globus Medical, Maintains $79 Price Target
Benzinga Newsdesk
-
Feb 21, 2024, 9:05AM
Key Takeaways From Globus Medical Analyst Ratings
Benzinga Insights
-
Feb 21, 2024, 9:00AM
Tuesday, February 20, 2024
Globus Medical Reaffirms 2024 Guidance: Sees Adj. EPS $2.68-$2.70, Revenue $2.45B-$2.475B
Benzinga Newsdesk
-
Feb 20, 2024, 4:50PM
Globus Medical Q4 2023 Adj EPS $0.60 Misses $0.61 Estimate, Sales $616.53M Beat $607.09M Estimate
Benzinga Newsdesk
-
Feb 20, 2024, 4:40PM
Globus Medical: Q4 Earnings Insights
Benzinga Insights
-
Feb 20, 2024, 4:40PM
Earnings Scheduled For February 20, 2024
Benzinga Insights
-
Feb 20, 2024, 6:52AM
Monday, February 05, 2024
Globus Medical Appoints Keith Pfeil As COO And CFO
Benzinga Newsdesk
-
Feb 5, 2024, 4:33PM
Thursday, January 11, 2024
The Analyst Verdict: Globus Medical In The Eyes Of 6 Experts
Benzinga Insights
-
Jan 11, 2024, 1:00PM
RBC Capital Reiterates Outperform on Globus Medical, Maintains $70 Price Target
Benzinga Newsdesk
-
Jan 11, 2024, 11:17AM
Wednesday, January 10, 2024
Globus Medical Sees FY24 Adj. EPS $2.68-$2.70 Vs $2.72 Est.; Revenue $2.450B-$2.475B Vs $2.47B Est.
Benzinga Newsdesk
-
Jan 10, 2024, 4:35PM
Globus Medical Reports Prelim. FY23 Revenue $1.567B Vs $1.55B Est.
Benzinga Newsdesk
-
Jan 10, 2024, 4:32PM
Globus Medical Reports Prelim. Q4 Revenue ~$615.5M Vs $602.26M Est.
Benzinga Newsdesk
-
Jan 10, 2024, 4:31PM
Friday, December 22, 2023
Truist Securities Maintains Hold on Globus Medical, Raises Price Target to $58
Benzinga Newsdesk
-
Dec 22, 2023, 9:49AM
Wednesday, December 20, 2023
Assessing Globus Medical: Insights From 5 Financial Analysts
Benzinga Insights
-
Dec 20, 2023, 9:00AM
Canaccord Genuity Maintains Buy on Globus Medical, Raises Price Target to $71
Benzinga Newsdesk
-
Dec 20, 2023, 8:15AM
Tuesday, November 14, 2023
Morgan Stanley Maintains Equal-Weight on Globus Medical, Lowers Price Target to $53
Benzinga Newsdesk
-
Nov 14, 2023, 9:22AM
Wednesday, November 08, 2023
Expert Ratings for Globus Medical
Benzinga Insights
-
Nov 8, 2023, 1:00PM
Truist Securities Maintains Hold on Globus Medical, Lowers Price Target to $53
Benzinga Newsdesk
-
Nov 8, 2023, 10:01AM
Tuesday, November 07, 2023
Globus Medical Increases FY23 Revenue Guidance From $1.25B To $1.55B vs $1.16B Est.
Benzinga Newsdesk
-
Nov 7, 2023, 4:43PM
Globus Medical Q3 Adj $0.57, Inline, Sales $383.64M Miss $435.17M Estimate
Benzinga Newsdesk
-
Nov 7, 2023, 4:40PM
Globus Medical: Q3 Earnings Insights
Benzinga Insights
-
Nov 7, 2023, 4:25PM
Earnings Scheduled For November 7, 2023
Benzinga Insights
-
Nov 7, 2023, 6:34AM
Wednesday, October 25, 2023
Shares of healthcare equipment and tools stocks are trading lower in sympathy with Thermo Fisher and Danaher.
Benzinga Newsdesk
-
Oct 25, 2023, 3:03PM
Friday, October 20, 2023
Benzinga's Top Ratings Upgrades, Downgrades For October 20, 2023
Benzinga Insights
-
Oct 20, 2023, 11:00AM
What 8 Analyst Ratings Have To Say About Globus Medical
Benzinga Insights
-
Oct 20, 2023, 8:00AM
Roth MKM Initiates Coverage On Globus Medical with Buy Rating, Announces Price Target of $75
Benzinga Newsdesk
-
Oct 20, 2023, 5:32AM
Thursday, October 12, 2023
Barclays Maintains Overweight on Globus Medical, Raises Price Target to $86
Benzinga Newsdesk
-
Oct 12, 2023, 2:20PM
Monday, October 02, 2023
Globus Medical On Sept 27 Approved New Stock Repurchase Program Authorizing Co To Repurchase Up To Additional $350M Of Its Class A Common Stock
Bill Haddad
-
Oct 2, 2023, 4:36PM
Stocks That Hit 52-Week Lows On Monday
Benzinga Insights
-
Oct 2, 2023, 1:00PM
Tuesday, September 19, 2023
Globus Medical's Untapped Potential Beyond The NUVA Transaction; Analyst Turns Bullish
Nabaparna Bhattacharya
-
Sep 19, 2023, 2:16PM
Benzinga's Top Ratings Upgrades, Downgrades For September 19, 2023
Benzinga Insights
-
Sep 19, 2023, 11:00AM
Stifel Upgrades Globus Medical to Buy, Announces $61 Price Target
Benzinga Newsdesk
-
Sep 19, 2023, 3:55AM
Friday, September 15, 2023
Wells Fargo Maintains Equal-Weight on Globus Medical, Lowers Price Target to $58
Benzinga Newsdesk
-
Sep 15, 2023, 11:39AM
Thursday, September 07, 2023
Globus Medical Announced The Commercial Launch Of NuVasive Specialized Orthopedics' (NSO) Precice Bone Transport System In Targeted Regions
Benzinga Newsdesk
-
Sep 7, 2023, 7:07AM
Tuesday, September 05, 2023
The Latest Analyst Ratings for Globus Medical
Benzinga Insights
-
Sep 5, 2023, 2:00PM
Truist Securities Reiterates Hold on Globus Medical, Maintains $65 Price Target
Benzinga Newsdesk
-
Sep 5, 2023, 10:21AM
Monday, August 07, 2023
Truist Securities Maintains Hold on Globus Medical, Lowers Price Target to $65
Benzinga Newsdesk
-
Aug 7, 2023, 10:29AM
Show more
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch